KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Treasury Shares (2016 - 2025)

Neogenomics (NEO) has disclosed Treasury Shares for 15 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 30.75% year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Dec 2025, up 30.75%, and an annual FY2025 reading of $2.8 million, up 30.75% over the prior year.
  • Treasury Shares was $2.8 million for Q4 2025 at Neogenomics, down from $3.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $3.1 million in Q2 2025 and bottomed at $331982.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $1.7 million, with a median of $2.0 million recorded in 2022.
  • Peak annual rise in Treasury Shares hit 384.07% in 2025, while the deepest fall reached 71.68% in 2025.
  • Year by year, Treasury Shares stood at $851403.0 in 2021, then soared by 134.3% to $2.0 million in 2022, then dropped by 1.65% to $2.0 million in 2023, then grew by 10.3% to $2.2 million in 2024, then surged by 30.75% to $2.8 million in 2025.
  • Business Quant data shows Treasury Shares for NEO at $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $3.1 million in Q2 2025.